Daiichi Sankyo Positions Its Covid Vaccine as a Booster in Japan

Daiichi Sankyo Co.’s home-grown Covid vaccine, a cutting-edge mRNA shot that’s on the cusp of its final clinical trials, could be used mainly as a booster starting next year for people who have …
( read original story …)